122299-11-0

122299-11-0 structure

Name: Eglin c (41-49)
Chemical Name: (3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-3-methyl-2-[[
CAS Number: 122299-11-0
Molecular Formula: C₄₈H₇₈N₁₂O₁₅
Molecular Weight: 1063.20000
Catalog: Research Areas Others
Create Date: 2016-11-09 13:41:26
Modify Date: 2024-01-03 20:08:49
Eglin c (41-49) is a peptide fragment related to eglin c. Eglin c (41-49) shows inhibitory effects to cathepsin G and α-chymotrypsin with Ki values of 42 and 20 μM, respectively[1].

Name	(3S)-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-3-methyl-2-[[
Synonyms	(3S)-4-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-[[(2S)-1,3-dihydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-3-methyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoyl]amino]butanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid Eglin c (41-49) H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OH Ser-pro-val-thr-leu-asp-leu-arg-tyr-OH

Description	Eglin c (41-49) is a peptide fragment related to eglin c. Eglin c (41-49) shows inhibitory effects to cathepsin G and α-chymotrypsin with Ki values of 42 and 20 μM, respectively[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
References	[1]. Okada Y, et al. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin. Biochem Biophys Res Commun. 1989 May 30;161(1):272-5.

133898-40-5

~81%

122299-11-0

Literature: Tsuboi; Takeda; Okada; Nagamatsu; Yamamoto Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 1 p. 184 - 186

Precursor 1
133898-40-5
DownStream 0